Literature DB >> 20047337

NMR mapping of the IFNAR1-EC binding site on IFNalpha2 reveals allosteric changes in the IFNAR2-EC binding site.

Sabine Ruth Akabayov1, Zohar Biron, Peter Lamken, Jacob Piehler, Jacob Anglister.   

Abstract

All type I interferons (IFNs) bind to a common cell-surface receptor consisting of two subunits. IFNs initiate intracellular signal transduction cascades by simultaneous interaction with the extracellular domains of its receptor subunits, IFNAR1 and IFNAR2. In this study, we mapped the surface of IFNalpha2 interacting with the extracellular domain of IFNAR1 (IFNAR1-EC) by following changes in or the disappearance of the (1)H-(15)N TROSY-HSQC cross peaks of IFNalpha2 caused by the binding of the extracellular domain of IFNAR1 (IFNAR1-EC) to the binary complex of IFNalpha2 with IFNAR2-EC. The NMR study of the 89 kDa complex was conducted at pH 8 and 308 K using an 800 MHz spectrometer. IFNAR1 binding affected a total of 47 of 165 IFNalpha2 residues contained in two large patches on the face of the protein opposing the binding site for IFNAR2 and in a third patch located on the face containing the IFNAR2 binding site. The first two patches form the IFNAR1 binding site, and one of these matches the IFNAR1 binding site previously identified by site-directed mutagenesis. The third patch partially matches the IFNalpha2 binding site for IFNAR2-EC, indicating allosteric communication between the binding sites for the two receptor subunits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20047337      PMCID: PMC2827818          DOI: 10.1021/bi901313x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding.

Authors:  Jordan H Chill; Sabine R Quadt; Rina Levy; Gideon Schreiber; Jacob Anglister
Journal:  Structure       Date:  2003-07       Impact factor: 5.006

2.  Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site.

Authors:  Laila C Roisman; Diego A Jaitin; Darren P Baker; Gideon Schreiber
Journal:  J Mol Biol       Date:  2005-10-21       Impact factor: 5.469

3.  Protein structure alignment by incremental combinatorial extension (CE) of the optimal path.

Authors:  I N Shindyalov; P E Bourne
Journal:  Protein Eng       Date:  1998-09

4.  Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography.

Authors:  R Radhakrishnan; L J Walter; A Hruza; P Reichert; P P Trotta; T L Nagabhushan; M R Walter
Journal:  Structure       Date:  1996-12-15       Impact factor: 5.006

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.

Authors:  L A Goldman; E C Cutrone; A Dang; X Hao; J K Lim; J A Langer
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

7.  Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.

Authors:  Peter Lamken; Martynas Gavutis; Imke Peters; José Van der Heyden; Gilles Uzé; Jacob Piehler
Journal:  J Mol Biol       Date:  2005-07-15       Impact factor: 5.469

8.  An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities.

Authors:  Eyal Kalie; Diego A Jaitin; Renne Abramovich; Gideon Schreiber
Journal:  J Biol Chem       Date:  2007-02-19       Impact factor: 5.157

9.  Erythropoietin receptor activation by a ligand-induced conformation change.

Authors:  I Remy; I A Wilson; S W Michnick
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

Review 10.  Interferons, interferon-like cytokines, and their receptors.

Authors:  Sidney Pestka; Christopher D Krause; Mark R Walter
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

View more
  6 in total

Review 1.  Cytokine-receptor interactions as drug targets.

Authors:  Gideon Schreiber; Mark R Walter
Journal:  Curr Opin Chem Biol       Date:  2010-07-07       Impact factor: 8.822

Review 2.  The molecular basis for differential type I interferon signaling.

Authors:  Gideon Schreiber
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

3.  Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity.

Authors:  Christopher D Krause; Gina Digioia; Lara S Izotova; Junxia Xie; Youngsun Kim; Barbara J Schwartz; Olga V Mirochnitchenko; Sidney Pestka
Journal:  Cytokine       Date:  2013-07-03       Impact factor: 3.861

Review 4.  Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.

Authors:  Jacob Piehler; Christoph Thomas; K Christopher Garcia; Gideon Schreiber
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

5.  Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY.

Authors:  Ilona Nudelman; Sabine R Akabayov; Einat Schnur; Zohar Biron; Rina Levy; Yingqi Xu; Daiwen Yang; Jacob Anglister
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

6.  Type-1 interferons contribute to oxygen glucose deprivation induced neuro-inflammation in BE(2)M17 human neuroblastoma cells.

Authors:  Myles Robert Minter; Moses Zhang; Robert Charles Ates; Juliet Marie Taylor; Peter John Crack
Journal:  J Neuroinflammation       Date:  2014-03-06       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.